Home
JANX
JANX News

Latest Janux Therapeutics Inc. (JANX) News on January 22, 2025

Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million

Business Wire

2 months ago

Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million

MT Newswires

2 months ago

Janux Therapeutics Prices $350 Million Offering of Shares, Warrants

Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Business Wire

2 months ago

Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Why Janux Therapeutics Crushed the Market Today

Motley Fool

2 months ago

Why Janux Therapeutics Crushed the Market Today

JANX Stock Hits Record High on Prostate Cancer Study Data

Zacks

2 months ago

JANX Stock Hits Record High on Prostate Cancer Study Data

MT Newswires

2 months ago

Janux Therapeutics Launches $300 Million Offering

Janux Catapults 49% On 'Unprecedented' Results In Prostate Cancer; Vir Goes For A Ride

Investor's Business Daily

2 months ago

Janux Catapults 49% On 'Unprecedented' Results In Prostate Cancer; Vir Goes For A Ride

Janux Therapeutics Announces Proposed Public Offering

Business Wire

2 months ago

Janux Therapeutics Announces Proposed Public Offering

MT Newswires

2 months ago

Sector Update: Health Care Stocks Mixed Late Afternoon

MT Newswires

2 months ago

Sector Update: Health Care Stocks Higher Tuesday Afternoon

MT Newswires

2 months ago

Sector Update: Health Care

MT Newswires

2 months ago

Janux Therapeutics Shares Soar After Reporting 'Positive' Interim Data for JANX007 in Prostate Cancer Patients

Janux Rockets 41% in Five Days as Cancer Breakthrough Fuels Market Buzz

GuruFocus.com

2 months ago

Janux Rockets 41% in Five Days as Cancer Breakthrough Fuels Market Buzz

Janux Therapeutics Stock Soars on Prostate Cancer Drug Trial Results

Barrons.com

2 months ago

Janux Therapeutics Stock Soars on Prostate Cancer Drug Trial Results

GuruFocus.com

2 months ago

Janux Skyrockets: 69% Surge This Morning Leads to 650% Gain in a Year

Janux, Vir Catapult On 'Unprecedented' Results In Prostate Cancer Patients

Investor's Business Daily

2 months ago

Janux, Vir Catapult On 'Unprecedented' Results In Prostate Cancer Patients

MT Newswires

2 months ago

Scotiabank Raises Price Target on Janux Therapeutics to $62 From $42, Keeps Sector Perform Rating

MT Newswires

2 months ago

Top Premarket Gainers

Business Wire

2 months ago

Janux Announces Doses Selected for Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC

MT Newswires

2 months ago

Janux Therapeutics Insider Sold Shares Worth $1,289,879, According to a Recent SEC Filing

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies

Business Wire

2 months ago

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies

Janux Therapeutics initiated with an Outperform at Leerink

TipRanks

2 months ago

Janux Therapeutics initiated with an Outperform at Leerink

MT Newswires

2 months ago

Leerink Initiates Janux Therapeutics at Outperform With $79 Price Target

Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors

Barrons.com

2 months ago

Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors

Janux Therapeutics Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

2 months ago

Janux Therapeutics Third Quarter 2024 Earnings: Misses Expectations

MT Newswires

2 months ago

Wedbush Adjusts Janux Therapeutics Price Target to $75 From $74, Maintains Outperform Rating

Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Business Wire

3 months ago

Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Bath & Body Works, Paramount Global, and More Stocks See Action From Activist Investors

Barrons.com

3 months ago

Bath & Body Works, Paramount Global, and More Stocks See Action From Activist Investors

MT Newswires

3 months ago

UBS Initiates Janux Therapeutics With Buy Rating, $69 Price Target

Paradigm Biocapital Advisors LP Acquires Shares in Janux Therapeutics Inc

GuruFocus.com

3 months ago

Paradigm Biocapital Advisors LP Acquires Shares in Janux Therapeutics Inc

RA Capital Management Reduces Stake in Janux Therapeutics

GuruFocus.com

3 months ago

RA Capital Management Reduces Stake in Janux Therapeutics

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 10/21/2024

Janux Therapeutics (NASDAQ:JANX) Is In A Strong Position To Grow Its Business

Simply Wall St.

3 months ago

Janux Therapeutics (NASDAQ:JANX) Is In A Strong Position To Grow Its Business

Janux Therapeutics, Inc. (JANX): A Hot Stock to Buy Now

Insider Monkey

3 months ago

Janux Therapeutics, Inc. (JANX): A Hot Stock to Buy Now

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 10/01/2024

MT Newswires

4 months ago

Janux Therapeutics Insider Sold Shares Worth $2,297,755, According to a Recent SEC Filing

MT Newswires

4 months ago

Janux Therapeutics Insider Sold Shares Worth $1,157,641, According to a Recent SEC Filing

Is Janux Therapeutics Inc. (JANX) the Best Performing Small-Cap Stock in 2024?

Insider Monkey

4 months ago

Is Janux Therapeutics Inc. (JANX) the Best Performing Small-Cap Stock in 2024?

Lennar, Bitdeer, and More Stocks See Action From Activist Investors

Barrons.com

4 months ago

Lennar, Bitdeer, and More Stocks See Action From Activist Investors

GuruFocus.com

4 months ago

RA Capital Management L.P. Increases Stake in Janux Therapeutics Inc

Janux Therapeutics, Inc. (JANX): Among Hedge Funds’ Top Biotech Stock Picks

Insider Monkey

4 months ago

Janux Therapeutics, Inc. (JANX): Among Hedge Funds’ Top Biotech Stock Picks

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 09/13/2024

Janux Therapeutics (JANX) Moves 6.5% Higher: Will This Strength Last?

Zacks

4 months ago

Janux Therapeutics (JANX) Moves 6.5% Higher: Will This Strength Last?

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 09/11/2024

MT Newswires

5 months ago

Stifel Nicolaus Initiates Coverage on Janux Therapeutics With Buy Rating, $70 Price Target

Southwest Airlines, Rocket Lab USA, and More Stocks See Action From Activist Investors

Barrons.com

5 months ago

Southwest Airlines, Rocket Lab USA, and More Stocks See Action From Activist Investors

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Tops Revenue Estimates

Zacks

5 months ago

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Tops Revenue Estimates

Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

Business Wire

5 months ago

Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

Janux Therapeutics Announces Updates to Board of Directors

Business Wire

6 months ago

Janux Therapeutics Announces Updates to Board of Directors

TruBridge, Evans Bancorp, and More Stocks See Action From Activist Investors

Barrons.com

7 months ago

TruBridge, Evans Bancorp, and More Stocks See Action From Activist Investors

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

7 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

7 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

7 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

7 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

7 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

7 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

7 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

7 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 06/06/2024

MT Newswires

8 months ago

Janux Therapeutics Insider Sold Shares Worth $45,043,975, According to a Recent SEC Filing

MT Newswires

8 months ago

Janux Therapeutics Insider Sold Shares Worth $82,125,000, According to a Recent SEC Filing

MT Newswires

8 months ago

Scotiabank Starts Janux Therapeutics With Sector Perform Rating

We're Not Very Worried About Janux Therapeutics' (NASDAQ:JANX) Cash Burn Rate

Simply Wall St.

8 months ago

We're Not Very Worried About Janux Therapeutics' (NASDAQ:JANX) Cash Burn Rate

MT Newswires

8 months ago

Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating

Janux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates

GuruFocus.com

8 months ago

Janux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates

Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Business Wire

8 months ago

Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength

Zacks

9 months ago

Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength

Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors

Zacks

9 months ago

Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors

Janux Therapeutics (JANX) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

9 months ago

Janux Therapeutics (JANX) is on the Move, Here's Why the Trend Could be Sustainable

Why Janux Therapeutics Stock Is Crushing It This Week

Motley Fool

9 months ago

Why Janux Therapeutics Stock Is Crushing It This Week

Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?

Benzinga

9 months ago

Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?

Wall Street Analysts Think Janux Therapeutics (JANX) Could Surge 40.3%: Read This Before Placing a Bet

Zacks

9 months ago

Wall Street Analysts Think Janux Therapeutics (JANX) Could Surge 40.3%: Read This Before Placing a Bet

Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options

Investor's Business Daily

9 months ago

Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options

Why Janux Therapeutics Stock Soared as the Market Sagged Today

Motley Fool

9 months ago

Why Janux Therapeutics Stock Soared as the Market Sagged Today

After Plunging -11.78% in 4 Weeks, Here's Why the Trend Might Reverse for Janux Therapeutics (JANX)

Zacks

9 months ago

After Plunging -11.78% in 4 Weeks, Here's Why the Trend Might Reverse for Janux Therapeutics (JANX)

Janux Therapeutics (JANX) Upgraded to Buy: Here's What You Should Know

Zacks

10 months ago

Janux Therapeutics (JANX) Upgraded to Buy: Here's What You Should Know

Wall Street Analysts Believe Janux Therapeutics (JANX) Could Rally 57.47%: Here's is How to Trade

Zacks

10 months ago

Wall Street Analysts Believe Janux Therapeutics (JANX) Could Rally 57.47%: Here's is How to Trade

Cancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst

Benzinga

10 months ago

Cancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst

2 Stocks That Have More Than Tripled This Year: Are They Buys?

Motley Fool

10 months ago

2 Stocks That Have More Than Tripled This Year: Are They Buys?

GuruFocus.com

10 months ago

Janux Therapeutics Inc (JANX) Reports Encouraging Clinical Data and Solid Financial Position ...

Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Business Wire

10 months ago

Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

The Zacks Analyst Blog Highlights Janux Therapeutics, SoundHound, Root, Equillium and CleanSpark

Zacks

a year ago

The Zacks Analyst Blog Highlights Janux Therapeutics, SoundHound, Root, Equillium and CleanSpark

After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy?

Motley Fool

a year ago

After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy?

5 Stocks That More Than Doubled in February

Zacks

a year ago

5 Stocks That More Than Doubled in February

Recent Price Trend in Janux Therapeutics, Inc. (JANX) is Your Friend, Here's Why

Zacks

a year ago

Recent Price Trend in Janux Therapeutics, Inc. (JANX) is Your Friend, Here's Why

Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Business Wire

a year ago

Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Janux Therapeutics Announces Proposed Public Offering of Common Stock

Business Wire

a year ago

Janux Therapeutics Announces Proposed Public Offering of Common Stock

Janux Stock Launches 230% On Its 'Significant Opportunity' In Prostate Cancer Treatment

Investor's Business Daily

a year ago

Janux Stock Launches 230% On Its 'Significant Opportunity' In Prostate Cancer Treatment

Janux shares triple on early cancer immunotherapy data

BioPharma Dive

a year ago

Janux shares triple on early cancer immunotherapy data

Janux Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for PSMAxCD3-TRACTr JANX007 in mCRPC and EGFRxCD3-TRACTr JANX008 in Solid Tumors

Business Wire

a year ago

Janux Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for PSMAxCD3-TRACTr JANX007 in mCRPC and EGFRxCD3-TRACTr JANX008 in Solid Tumors

Janux Therapeutics, Inc. (JANX) Moves 5.6% Higher: Will This Strength Last?

Zacks

a year ago

Janux Therapeutics, Inc. (JANX) Moves 5.6% Higher: Will This Strength Last?

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008

Business Wire

a year ago

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008

Inovio (INO) Moves 17.4% Higher: Will This Strength Last?

Zacks

a year ago

Inovio (INO) Moves 17.4% Higher: Will This Strength Last?

13 Best Aerospace Stocks To Buy On Sale

Insider Monkey

a year ago

13 Best Aerospace Stocks To Buy On Sale

CENTERSPACE APPOINTS OLA OYINSAN HIXON TO BOARD OF TRUSTEES

PR Newswire

a year ago

CENTERSPACE APPOINTS OLA OYINSAN HIXON TO BOARD OF TRUSTEES

Independent Bank Corporation Reports 2023 Fourth Quarter Results

GlobeNewswire

a year ago

Independent Bank Corporation Reports 2023 Fourth Quarter Results

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/25/2024

Are Robust Financials Driving The Recent Rally In Precision Drilling Corporation's (TSE:PD) Stock?

Simply Wall St.

a year ago

Are Robust Financials Driving The Recent Rally In Precision Drilling Corporation's (TSE:PD) Stock?

Zacks Industry Outlook Highlights Frontier Communications and Weave Communications

Zacks

a year ago

Zacks Industry Outlook Highlights Frontier Communications and Weave Communications

Bristow Enters Into New Long-term Equipment Financing for up to £55 Million

PR Newswire

a year ago

Bristow Enters Into New Long-term Equipment Financing for up to £55 Million

Share on Social Networks: